Rubius Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rubius Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2022.
  • Rubius Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was $2.96M.
  • Rubius Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$1.22M, a 36.8% increase year-over-year.
  • Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.22M, a 36.8% increase from 2021.
  • Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.93M, a 50.5% decline from 2020.
  • Rubius Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.28M, a 121% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.22M +$711K +36.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 -$1.93M -$648K -50.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 -$1.28M -$7.43M -121% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $6.14M +$3.68M +149% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $2.47M +$3.05M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$583K -$419K -255% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$164K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.